Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 204

1.

Open letter to Lady Scotland.

Weller D, Lodge M, Eden T, Fleming D, Bouffet E, Schocken C, Magrath I, Rosser J, Joubert E, Rodriguez-Galindo C, Denny L, Vallejo-Auste C; signatories..

Lancet Oncol. 2017 Apr;18(4):e194. doi: 10.1016/S1470-2045(17)30205-X. No abstract available.

PMID:
28368256
2.

Access to essential medicines for children with cancer: a joint SIOP-CCI position statement.

Denburg A, Arora B, Arora RS, Auste C, Bagai P, Barr R, Challinor J, Eden T, Grynzspancholc E, Hoffman R, Link M.

Lancet Oncol. 2017 Jan;18(1):20-22. doi: 10.1016/S1470-2045(16)30652-0. No abstract available.

PMID:
28049570
3.

Rural Shop-Based Health Program Planning: a Formative Research Approach Among Owners.

Hall MB, Eden TM, Bess JJ, Landrine H, Corral I, Guidry JJ, Efird JT.

J Racial Ethn Health Disparities. 2016 Jun 20. [Epub ahead of print]

PMID:
27324819
4.

Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL; NORDIC Idiopathic Intracranial Hypertension Study Group..

Invest Ophthalmol Vis Sci. 2016 Mar;57(3):805-12. doi: 10.1167/iovs.15-18626.

5.

The surgeon's role in childhood cancer worldwide.

Eden T, Burns L.

Lancet Oncol. 2015 Sep;16(11):1191-2. doi: 10.1016/S1470-2045(15)00293-4. No abstract available.

PMID:
26427362
6.

Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension.

Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, Patel AD, Bruce BB, He H, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group..

Neurology. 2015 Sep 1;85(9):799-805. doi: 10.1212/WNL.0000000000001896. Epub 2015 Aug 5.

7.

The Collaborative Wilms Tumour Africa Project; baseline evaluation of Wilms tumour treatment and outcome in eight institutes in sub-Saharan Africa.

Paintsil V, David H, Kambugu J, Renner L, Kouya F, Eden T, Hesseling P, Molyneux E, Israels T.

Eur J Cancer. 2015 Jan;51(1):84-91. doi: 10.1016/j.ejca.2014.10.030. Epub 2014 Nov 19.

PMID:
25465189
8.

Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.

OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group., Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith MJ, Sibony P, Plumb K, Wang JK, Werner JS.

Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8173-9. doi: 10.1167/iovs.14-14961.

9.

Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.

OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group., Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS.

Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8180-8. doi: 10.1167/iovs.14-14960.

10.

Assessment of vascular and endothelial dysfunction in nutritional studies.

Ray S, Miglio C, Eden T, Del Rio D.

Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):940-6. doi: 10.1016/j.numecd.2014.03.011. Epub 2014 Apr 18. Review.

PMID:
24925123
11.

Nutrition education and leadership for improved clinical outcomes: training and supporting junior doctors to run 'Nutrition Awareness Weeks' in three NHS hospitals across England.

Ray S, Laur C, Douglas P, Rajput-Ray M, van der Es M, Redmond J, Eden T, Sayegh M, Minns L, Griffin K, McMillan C, Adiamah A, Gillam S, Gandy J.

BMC Med Educ. 2014 May 29;14:109. doi: 10.1186/1472-6920-14-109.

12.

Separated response function ratios in exclusive, forward π(±) electroproduction.

Huber GM, Blok HP, Butuceanu C, Gaskell D, Horn T, Mack DJ, Abbott D, Aniol K, Anklin H, Armstrong C, Arrington J, Assamagan K, Avery S, Baker OK, Barrett B, Beise EJ, Bochna C, Boeglin W, Brash EJ, Breuer H, Chang CC, Chant N, Christy ME, Dunne J, Eden T, Ent R, Fenker H, Gibson EF, Gilman R, Gustafsson K, Hinton W, Holt RJ, Jackson H, Jin S, Jones MK, Keppel CE, Kim PH, Kim W, King PM, Klein A, Koltenuk D, Kovaltchouk V, Liang M, Liu J, Lolos GJ, Lung A, Margaziotis DJ, Markowitz P, Matsumura A, McKee D, Meekins D, Mitchell J, Miyoshi T, Mkrtchyan H, Mueller B, Niculescu G, Niculescu I, Okayasu Y, Pentchev L, Perdrisat C, Pitz D, Potterveld D, Punjabi V, Qin LM, Reimer PE, Reinhold J, Roche J, Roos PG, Sarty A, Shin IK, Smith GR, Stepanyan S, Tang LG, Tadevosyan V, Tvaskis V, van der Meer RL, Vansyoc K, Van Westrum D, Vidakovic S, Volmer J, Vulcan W, Warren G, Wood SA, Xu C, Yan C, Zhao WX, Zheng X, Zihlmann B; Jefferson Lab Fπ Collaboration..

Phys Rev Lett. 2014 May 9;112(18):182501. Epub 2014 May 5.

PMID:
24856691
13.

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee., Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ.

JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312.

14.

The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group..

JAMA Neurol. 2014 Jun;71(6):693-701. doi: 10.1001/jamaneurol.2014.133.

15.

The idiopathic intracranial hypertension treatment trial: design considerations and methods.

Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL, Feldon SE, Schron E, Corbett JJ, Wall M; NORDIC IIHTT Study Group..

J Neuroophthalmol. 2014 Jun;34(2):107-17. doi: 10.1097/WNO.0000000000000114.

PMID:
24739993
16.

Brief report on pediatric oncology in Bangladesh.

Islam A, Eden T.

South Asian J Cancer. 2013 Apr;2(2):105-6. doi: 10.4103/2278-330X.110516.

17.

Is communication guidance mistaken? Qualitative study of parent-oncologist communication in childhood cancer.

Young B, Hill J, Gravenhorst K, Ward J, Eden T, Salmon P.

Br J Cancer. 2013 Aug 20;109(4):836-43. doi: 10.1038/bjc.2013.413. Epub 2013 Jul 30.

18.

Clinical trials to improve childhood cancer care and survival in sub-Saharan Africa.

Israëls T, Kambugu J, Kouya F, El-Mallawany NK, Hesseling PB, Kaspers GJ, Eden T, Renner L, Molyneux EM.

Nat Rev Clin Oncol. 2013 Oct;10(10):599-604. doi: 10.1038/nrclinonc.2013.137. Epub 2013 Jul 30. Review.

PMID:
23897077
19.

Young people describe their prediagnosis cancer experience.

Gibson F, Pearce S, Eden T, Glaser A, Hooker L, Whelan J, Kelly D.

Psychooncology. 2013 Nov;22(11):2585-92. doi: 10.1002/pon.3325. Epub 2013 Jun 20.

PMID:
23784978
20.

Size threshold perimetry performs as well as conventional automated perimetry with stimulus sizes III, V, and VI for glaucomatous loss.

Wall M, Doyle CK, Eden T, Zamba KD, Johnson CA.

Invest Ophthalmol Vis Sci. 2013 Jun 7;54(6):3975-83. doi: 10.1167/iovs.12-11300.

PMID:
23633660

Supplemental Content

Loading ...
Support Center